Stocks
CEL-SCI CorporationCVM
AMEXHealthcareBiotechnology$1.62
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer and infectious diseases. Its lead product candidate, Multikine, is being evaluated in head and neck cancer trials, with investors tracking regulatory milestones and trial data. The company has no approved products and relies on funding to advance its pipeline.
52W Range: $0.89-$9.35
Congressional Interest in CEL-SCI Corporation (CVM)
No congressional trades have been disclosed for CEL-SCI Corporation (CVM) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CVM?
No congressional trades found for this stock.